Literature DB >> 15150111

Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility.

Debra L Silver1, Honami Naora, Jinsong Liu, Wenjun Cheng, Denise J Montell.   

Abstract

Constitutive activation of the Janus-activated kinase/signal transducer and activator of transcription (STAT) pathway promotes the proliferation and survival of cancer cells in culture and is associated with various cancers, including those of the ovary. We found that constitutively activated STAT3 levels correlated with aggressive clinical behavior of ovarian carcinoma specimens. Furthermore, inhibition of STAT3 reduced the motility of ovarian cancer cells in vitro. Surprisingly, we found that activated STAT3 localized not only to nuclei but also to focal adhesions in these cells. Activated STAT3 coimmunoprecipitated with phosphorylated paxillin and focal adhesion kinase and required paxillin and Src for its localization to focal adhesions. These results suggest that Janus-activated kinase/STAT signaling may contribute to ovarian cancer cell invasiveness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150111     DOI: 10.1158/0008-5472.CAN-03-3959

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  101 in total

1.  Phaeosphaeride A, an inhibitor of STAT3-dependent signaling isolated from an endophytic fungus.

Authors:  Katherine N Maloney; Wenshan Hao; Jun Xu; Jay Gibbons; John Hucul; Deborah Roll; Sean F Brady; Frank C Schroeder; Jon Clardy
Journal:  Org Lett       Date:  2006-08-31       Impact factor: 6.005

2.  STAT3-stathmin interactions control microtubule dynamics in migrating T-cells.

Authors:  Navin K Verma; Jennifer Dourlat; Anthony M Davies; Aideen Long; Wang-Qing Liu; Christiane Garbay; Dermot Kelleher; Yuri Volkov
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

Review 3.  Cell motility in cancer invasion and metastasis: insights from simple model organisms.

Authors:  Christina H Stuelten; Carole A Parent; Denise J Montell
Journal:  Nat Rev Cancer       Date:  2018-03-16       Impact factor: 60.716

Review 4.  Inflammation: a driving force speeds cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

5.  Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.

Authors:  Belen Elguero; Geraldine Gueron; Jimena Giudice; Martin A Toscani; Paola De Luca; Florencia Zalazar; Federico Coluccio-Leskow; Roberto Meiss; Nora Navone; Adriana De Siervi; Elba Vazquez
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

6.  The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.

Authors:  Michael Hedvat; Dennis Huszar; Andreas Herrmann; Joseph M Gozgit; Anne Schroeder; Adam Sheehy; Ralf Buettner; David Proia; Claudia M Kowolik; Hong Xin; Brian Armstrong; Geraldine Bebernitz; Shaobu Weng; Lin Wang; Minwei Ye; Kristen McEachern; Huawei Chen; Deborah Morosini; Kirsten Bell; Marat Alimzhanov; Stephanos Ioannidis; Patricia McCoon; Zhu A Cao; Hua Yu; Richard Jove; Michael Zinda
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

7.  Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.

Authors:  Galina Gritsina; Fang Xiao; Shane W O'Brien; Rashid Gabbasov; Marisa A Maglaty; Ren-Huan Xu; Roshan J Thapa; Yan Zhou; Emmanuelle Nicolas; Samuel Litwin; Siddharth Balachandran; Luis J Sigal; Dennis Huszar; Denise C Connolly
Journal:  Mol Cancer Ther       Date:  2015-02-02       Impact factor: 6.261

8.  Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.

Authors:  Keinosuke Ryu; Michiro Susa; Edwin Choy; Cao Yang; Francis J Hornicek; Henry J Mankin; Zhenfeng Duan
Journal:  BMC Cancer       Date:  2010-05-10       Impact factor: 4.430

9.  Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.

Authors:  S E Wheeler; S Suzuki; S M Thomas; M Sen; R J Leeman-Neill; S I Chiosea; C-T Kuan; D D Bigner; W E Gooding; S Y Lai; J R Grandis
Journal:  Oncogene       Date:  2010-07-12       Impact factor: 9.867

10.  Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.

Authors:  M Colomiere; A C Ward; C Riley; M K Trenerry; D Cameron-Smith; J Findlay; L Ackland; N Ahmed
Journal:  Br J Cancer       Date:  2008-12-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.